LCN2 and congestive heart failure: Adding the serum NGAL levels to a traditional risk model improved the prediction value for AMI (HR = 0.157, 95% CI = 0.0308–0.2831, p = 0.019), CV death (HR = 0.230, 95% CI = 0.0736–0.3866, p = 0.005), CHF (HR = 0.145, 95% CI = 0.0281–0.2612, p = 0.020), MACE (HR = 0.182, 95% CI = 0.0812–0.282, p = 0.001), composite of CV events (HR = 0.145, 95% CI = 0.0543 ∼ 0.2355, p = 0.003), target vessel revascularization (HR = 0.205, 95% CI = 0.1094–0.2996, p < 0.001) and new-onset hemodialysis (HR = 0.276, 95% CI = 0.0592–0.4925, p < 0.014), as shown by the significant NRI value.